Changes in intestinal flora in patients with extrahepatic cholangiocarcinoma

Tao LI; Panliang WANG; Zibo YUAN; Quankai FENG; Jie LI

doi:10.3969/j.issn.1001-5256.2021.12.029

Volume 37 Issue 12

Dec. 2021

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2021 > 37(12): 2883-2889

PDF( 5925 KB)

Changes in intestinal flora in patients with extrahepatic cholangiocarcinoma

DOI: 10.3969/j.issn.1001-5256.2021.12.029

Tao LI^{1, 2, 3},
Panliang WANG^{2, 3},
Zibo YUAN^{1, 2, 3},
Quankai FENG^{1, 2, 3},
Jie LI^{1, 2, 3
,
,}

1.
Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
2.
Henan Key Laboratory of Digestive Organ Transplantation, Zhengzhou 450052, China
3.
Zhengzhou Key Laboratory of Organ Transplantation Technology and Application Engineering, Zhengzhou 450052, China

Research funding:

National Natural Science Foundation of China (81900596)

Received Date: 2021-07-30
Accepted Date: 2021-08-31
Published Date: 2021-12-20

Abstract

Abstract

Objective To investigate the changes in intestinal flora in patients with extrahepatic cholangiocarcinoma (ECC) and related influencing factors. Methods Fecal samples were collected from 16 patients with ECC who were hospitalized and treated in Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, from January to December 2020, and absolute quantitative bacterial 16S rRNA was used for sequencing. A comparison was made with 20 patients with common bile duct stones (CBDS group) and 10 healthy controls (normal group), and the three groups were compared in terms of the differences in intestinal flora and the association with clinical indices. A one-way analysis of variance was used for comparison of normally distributed data with homogeneity of variance between the three groups, the t-test was used for comparison between two groups; the Kruskal-Wallis H test was used for comparison of non-normally distributed data between the three groups, and the Nemenyi test was used for comparison between groups. The chi-square test or the Fisher's exact test were used for comparison of categorical data between the three groups, and a Spearman correlation analysis was used to investigate correlation. Results The ECC group had significantly higher levels of total bilirubin (TBil) and direct bilirubin (DBil) than the CBDS group and the normal group. The α diversity analysis showed that there were no significant differences in observed species, Chao1 Index, and Shannon Index between the three groups (all P > 0.05), while there were significant differences in Shannon Index and Simpson Index between the three groups. The ECC group had a similar species diversity to the normal group and a significantly greater species diversity than the CBDS group (P < 0.05), and the CBDS group had a significantly greater species diversity than the normal group (P < 0.05). The β diversity analysis showed that the structure of intestinal flora in the ECC group was significantly different from that in the normal group and the CBDS group (P < 0.05). The analysis of the difference in bacterial composition showed that Prevotella, Lactobacillus, Megasphaera, and Sutterella were significantly enriched in the ECC group. The correlation analysis showed that Prevotella was negatively correlated with the use of antibiotics, acid inhibitors, and liver-protecting drugs, and Lactobacillus, Megasphaera, and Sutterella were positively correlated with TBil and DBil. Conclusion There is a significant change in intestinal flora in patients with ECC, which is closely associated with liver function and the use of drugs.
- Extrahepatic Cholangiocarcinoma,
- Gastrointestinal Microbiome,
- Absolute Quantitative Sequencing

FullText(HTML)

References(32)

References

[1]	RIZVI S, KHAN SA, HALLEMEIER CL, et al. Cholangiocarcinoma-evolving concepts and therapeutic strategies[J]. Nat Rev Clin Oncol, 2018, 15(2): 95-111. DOI: 10.1038/nrclinonc.2017.157.
[2]	TYSON GL, EL-SERAG HB. Risk factors for cholangiocarcinoma[J]. Hepatology, 2011, 54(1): 173-184. DOI: 10.1002/hep.24351.
[3]	BIEDERMANN L, ROGLER G. The intestinal microbiota: Its role in health and disease[J]. Eur J Pediatr, 2015, 174(2): 151-167. DOI: 10.1007/s00431-014-2476-2.
[4]	AKSHINTALA VS, TALUKDAR R, SINGH VK, et al. The gut microbiome in pancreatic disease[J]. Clin Gastroenterol Hepatol, 2019, 17(2): 290-295. DOI: 10.1016/j.cgh.2018.08.045.
[5]	BIEDERMANN L, ROGLER G. The intestinal microbiota: Its role in health and disease[J]. Eur J Pediatr, 2015, 174(2): 151-167. DOI: 10.1007/s00431-014-2476-2.
[6]	HAN ML, GONG ZH. The mechanism of intestinal flora in hepatobiliary diseases[J]. J Clin Hepatol, 2017, 33(2): 384-388. DOI: 10.3969/j.issn.1001-5256.2017.02.040. 韩美林, 龚振华. 肠道菌群在肝胆疾病中的作用机制[J]. 临床肝胆病杂志, 2017, 33(2): 384-388. DOI: 10.3969/j.issn.1001-5256.2017.02.040.
[7]	BENSON AB, D'ANGELICA MI, ABBOTT DE, et al. Hepatobiliary cancers, version 1.2020, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2020, 10(5): 541-565. DOI: 10.6004/jnccn.2020.0036.
[8]	WILLIAMS E, BECKINGHAM I, EL SAYED G, et al. Updated guideline on the management of common bile duct stones (CBDS)[J]. Gut, 2017, 66(5): 765-782. DOI: 10.1136/gutjnl-2016-312317.
[9]	DOHERTY B, NAMBUDIRI VE, PALMER WC. Update on the diagnosis and treatment of cholangiocarcinoma[J]. Curr Gastroenterol Rep, 2017, 19(1): 2. DOI: 10.1007/s11894-017-0542-4.
[10]	JANG JY, KIM SW, PARK DJ, et al. Actual long-term outcome of extrahepatic bile duct cancer after surgical resection[J]. Ann Surg, 2005, 241(1): 77-84. DOI: 10.1097/01.sla.0000150166.94732.88.
[11]	LEE H, LEE HK, MIN SK, et al. 16S rDNA microbiome composition pattern analysis as a diagnostic biomarker for biliary tract cancer[J]. World J Surg Oncol, 2020, 18(1): 19. DOI: 10.1186/s12957-020-1793-3.
[12]	CHEN B, FU SW, LU L, et al. A Preliminary study of biliary microbiota in patients with bile duct stones or distal cholangiocarcinoma[J]. Biomed Res Int, 2019, 2019: 1092563. DOI: 10.1155/2019/1092563.
[13]	AVILÉS-JIMÉNEZ F, GUITRON A, SEGURA-LÓPEZ F, et al. Microbiota studies in the bile duct strongly suggest a role for Helicobacter pylori in extrahepatic cholangiocarcinoma[J]. Clin Microbiol Infect, 2016, 22(2): 178.e11-e22. DOI: 10.1016/j.cmi.2015.10.008.
[14]	WANG Q, HAO C, YAO W, et al. Intestinal flora imbalance affects bile acid metabolism and is associated with gallstone formation[J]. BMC Gastroenterol, 2020, 20(1): 59. DOI: 10.1186/s12876-020-01195-1.
[15]	WANG P, WANG Y, LU L, et al. Alterations in intestinal microbiota relate to intestinal failure-associated liver disease and central line infections[J]. J Pediatr Surg, 2017, 52(8): 1318-1326. DOI: 10.1016/j.jpedsurg.2017.04.020.
[16]	HⅡPPALA K, KAINULAINEN V, KALLIOMÄKI M, et al. Mucosal prevalence and interactions with the epithelium indicate commensalism of sutterella spp[J]. Front Microbiol, 2016, 7: 1706. DOI: 10.3389/fmicb.2016.01706.
[17]	KAAKOUSH NO. Sutterella species, iga-degrading bacteria in ulcerative colitis[J]. Trends Microbiol, 2020, 28(7): 519-522. DOI: 10.1016/j.tim.2020.02.018.
[18]	WEXLER HM. Bacteroides: The good, the bad, and the nitty-gritty[J]. Clin Microbiol Rev, 2007, 20(4): 593-621. DOI: 10.1128/CMR.00008-07.
[19]	GIBⅡNO G, LOPETUSO LR, SCALDAFERRI F, et al. Exploring bacteroidetes: Metabolic key points and immunological tricks of our gut commensals[J]. Dig Liver Dis, 2018, 50(7): 635-639. DOI: 10.1016/j.dld.2018.03.016.
[20]	YANG PJ, HUANG W, LIU HB. The correlation between IL-17 and liver disease[J]. J Clin Hepatol, 2017, 33(9): 1810-1814. DOI: 10.3969/j.issn.1001-5256.2017.09.041. 杨浦娟, 黄祎, 刘华宝. IL-17与肝脏疾病的相关性[J]. 临床肝胆病杂志, 2017, 33(9): 1810-1814. DOI: 10.3969/j.issn.1001-5256.2017.09.041.
[21]	BELLONE M, BREVI A, HUBER S. Microbiota-propelled T helper 17 cells in inflammatory diseases and cancer[J]. Microbiol Mol Biol Rev, 2020, 84(2): e00064-19. DOI: 10.1128/MMBR.00064-19.
[22]	VICH VILA A, COLLIJ V, SANNA S, et al. Impact of commonly used drugs on the composition and metabolic function of the gut microbiota[J]. Nat Commun, 2020, 11(1): 362. DOI: 10.1038/s41467-019-14177-z.
[23]	ZOU ZH, LIU D, LI HD, et al. Prenatal and postnatal antibiotic exposure influences the gut microbiota of preterm infants in neonatal intensive care units[J]. Ann Clin Microbiol Antimicrob, 2018, 17(1): 9. DOI: 10.1186/s12941-018-0264-y.
[24]	PLETZ MW, RAU M, BULITTA J, et al. Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers[J]. Antimicrob Agents Chemother, 2004, 48(10): 3765-3772. DOI: 10.1128/AAC.48.10.3765-3772.2004.
[25]	ZENG H, LARSON KJ, CHENG WH, et al. Advanced liver steatosis accompanies an increase in hepatic inflammation, colonic, secondary bile acids and Lactobacillaceae/Lachnospiraceae bacteria in C57BL/6 mice fed a high-fat diet[J]. J Nutr Biochem, 2020, 78: 108336. DOI: 10.1016/j.jnutbio.2019.108336.
[26]	LONG Z, KONG D. Research progress on pathogenic factors of extrahepatic cholangiocarcinoma[J]. Jiangxi Trad Chin Med, 2017, 48(8): 72-75. https://www.cnki.com.cn/Article/CJFDTOTAL-JXZY201708028.htm 龙祯, 孔棣. 肝外胆管癌致病因素的研究进展[J]. 江西中医药, 2017, 48(8): 72-75. https://www.cnki.com.cn/Article/CJFDTOTAL-JXZY201708028.htm
[27]	OHTANI N, KAWADA N. Role of the gut-liver axis in liver inflammation, fibrosis, and cancer: A special focus on the gut microbiota relationship[J]. Hepatol Commun, 2019, 3(4): 456-470. DOI: 10.1002/hep4.1331.
[28]	SHETTY SA, MARATHE NP, LANJEKAR V, et al. Comparative genome analysis of Megasphaera sp. reveals niche specialization and its potential role in the human gut[J]. PLoS One, 2013, 8(11): e79353. DOI: 10.1371/journal.pone.0079353.
[29]	AUDIRAC-CHALIFOUR A, TORRES-POVEDA K, BAHENA-ROMÁN M, et al. Cervical microbiome and cytokine profile at various stages of cervical cancer: A pilot study[J]. PLoS One, 2016, 11(4): e0153274. DOI: 10.1371/journal.pone.0153274.
[30]	GOPINATH D, KUNNATH MENON R, CHUN WIE C, et al. Salivary bacterial shifts in oral leukoplakia resemble the dysbiotic oral cancer bacteriome[J]. J Oral Microbiol, 2020, 13(1): 1857998. DOI: 10.1080/20002297.2020.1857998.
[31]	CORTEZ RV, MOREIRA LN, PADILHA M, et al. Gut microbiome of children and adolescents with primary sclerosing cholangitis in association with ulcerative colitis[J]. Front Immunol, 2020, 11: 598152. DOI: 10.3389/fimmu.2020.598152.
[32]	WU J, ZHANG C, XU S, et al. Fecal microbiome alteration may be a potential marker for gastric cancer[J]. Dis Markers, 2020, 2020: 3461315. DOI: 10.1155/2020/3461315.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(4) / Tables(2)

Get Citation

PDF

XML

Article Metrics

Article views (304) PDF downloads(26)

Changes in intestinal flora in patients with extrahepatic cholangiocarcinoma

DOI: 10.3969/j.issn.1001-5256.2021.12.029

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Changes in intestinal flora in patients with extrahepatic cholangiocarcinoma

DOI: 10.3969/j.issn.1001-5256.2021.12.029

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content